semaglutide peptides research Peptide – Pacific Research Semaglutide (GLP-1)

Rare side effects include dehydration, low blood pressure, and ketoacidosis

If we consider that around one in eight Americans have already tried a GLP-1 drug, according to healthy policy organisation KFF, and that more than two in five adults in the US live with obesity, there is real opportunity for pharma companies to meet this demand

Cepeda V et al

doi: 10.1155/2022/3210200 Summary Keywords glutamine, glutaminolysis, CD4 + T cells, autoimmune diseases, immune response Citation Feng X, Li X, Liu N, Hou N, Sun X and Liu Y (2022) Glutaminolysis and CD4 + T-cell metabolism in autoimmunity: From pathogenesis to therapy prospects